Opportunity ID: 334776

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-266
Funding Opportunity Title: NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 16, 2021
Last Updated Date: Nov 27, 2023
Original Closing Date for Applications: Apr 05, 2024
Current Closing Date for Applications: Nov 27, 2023
Archive Date: Dec 27, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description:

(Reissue of PAR-18-618) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-266.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date
expired and re-issued as PAR-23-311 Nov 27, 2023
Jul 16, 2021

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-266
Funding Opportunity Title: NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 16, 2021
Last Updated Date: Nov 27, 2023
Original Closing Date for Applications: Apr 05, 2024
Current Closing Date for Applications: Nov 27, 2023
Archive Date: Dec 27, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description:

(Reissue of PAR-18-618) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-266.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

grantsinfo@nih.gov
Email:grantsinfo@nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-266
Funding Opportunity Title: NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 16, 2021
Last Updated Date: Jul 16, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2024
Archive Date: May 11, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: (Reissue of PAR-18-618) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-266.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Folder 334776 Full Announcement-PAR-21-266 -> PAR-21-266-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00270936 Dec 16, 2021 Jan 24, 2023 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00268218 Aug 05, 2021 Jan 24, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278357 Nov 14, 2022 Nov 28, 2023 View

Package 1

Mandatory forms

334776 RR_SF424_5_0-5.0.pdf

334776 PHS398_CoverPageSupplement_5_0-5.0.pdf

334776 RR_OtherProjectInfo_1_4-1.4.pdf

334776 PerformanceSite_4_0-4.0.pdf

334776 RR_KeyPersonExpanded_4_0-4.0.pdf

334776 RR_Budget_3_0-3.0.pdf

334776 PHS398_ResearchPlan_4_0-4.0.pdf

334776 SBIR_STTR_Information_3_0-3.0.pdf

334776 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

334776 RR_SubawardBudget30_3_0-3.0.pdf

334776 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

334776 RR_SF424_2_0-2.0.pdf

334776 PHS398_CoverPageSupplement_5_0-5.0.pdf

334776 RR_OtherProjectInfo_1_4-1.4.pdf

334776 PerformanceSite_2_0-2.0.pdf

334776 RR_KeyPersonExpanded_2_0-2.0.pdf

334776 RR_Budget_1_4-1.4.pdf

334776 PHS398_ResearchPlan_4_0-4.0.pdf

334776 SBIR_STTR_Information_1_3-1.3.pdf

334776 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

334776 RR_SubawardBudget30_1_4-1.4.pdf

334776 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

334776 RR_SF424_5_0-5.0.pdf

334776 PHS398_CoverPageSupplement_5_0-5.0.pdf

334776 RR_OtherProjectInfo_1_4-1.4.pdf

334776 PerformanceSite_4_0-4.0.pdf

334776 RR_KeyPersonExpanded_4_0-4.0.pdf

334776 RR_Budget_3_0-3.0.pdf

334776 PHS398_ResearchPlan_5_0-5.0.pdf

334776 SBIR_STTR_Information_3_0-3.0.pdf

334776 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

334776 RR_SubawardBudget30_3_0-3.0.pdf

334776 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T14:58:52-05:00

Share This Post, Choose Your Platform!

About the Author: